As a proof of principle, we decided to assess the in vivo potential of the full-length anti–RRM1 TDP43 antibody to rescue ALS/FTLD pathological events in the TDP43A315T mouse model. Here, RRM1 is linked to amyotrophic lateral sclerosis.